Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
new york blog main
new york top stories
raleigh-durham blog main
3
×
raleigh-durham top stories
san francisco blog main
san francisco top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
glaxosmithkline
indiana blog main
indiana top stories
johnson & johnson
national
national top stories
president trump
san diego blog main
san diego top stories
satsuma pharmaceuticals
seattle blog main
seattle top stories
springworks therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
acute migrane
allergan
american society of clinical oncology (asco)
amgen
What
biotech
3
×
days
3
×
drug
roundup
activity
ahead
ambien
american
annual
asco
attendees
attention
august
bio
busy
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
companies
decisions
devices
dog
drugs
expanding
fda
firm
focus
hasn’t
home
ipo
ipos
key
kicks
leading
legacy
Language
unset
Current search:
days
×
biotech
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
